Insulin Prices: House Hearing Displays Bipartisan Commitment To Rapid Reform

Reform "is going to happen,” promised Energy & Commerce Oversight Subcommittee Chair Diana DeGette, suggesting the panel’s next hearing on insulin price reform may be held in July.

Rayburn House

US House Republicans and Democrats are frustrated with the measures pharmaceutical manufacturers and pharmacy benefit managers have taken to lower insulin prices and warned them at an April 10 hearing that a more radical solution is needed – and soon.

“What we’re going to do is get together in a bipartisan way and we’re going to work with all of...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access